Richard Afable serves as Executive at ACELRX PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Richard Afable has executed 6 insider transactions totaling $10.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 10, 2023 involved receiving (via award) 581 shares valued at $0.
Richard Afable currently holds 2,468 shares of ACELRX PHARMACEUTICALS INC (ACRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Afable has been a net buyer of ACRX stock. They have purchased $10.3K and sold $0 worth of shares.
Richard Afable's most recent insider trade was on Oct 10, 2023, when they sold 581 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 17, 2021 | ACRX | $0 | Award | 10,000 | $N/A | Discretionary |
| Jun 16, 2020 | ACRX | $0 | Award | 7,500 | $N/A | Discretionary |
| Jun 25, 2019 | ACRX | $0 | Award | 3,750 | $N/A | Discretionary |
| Jun 23, 2014 | ACRX | $10.3K | Purchase | 1,000 | $10.30 | Discretionary |